Phase
Condition
Pregnancy Complications
Treatment
17β-estradiol/dydrogesterone tablets
Clinical Study ID
Ages 18-40 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age between 18 years old (inclusive) and 40 years old (inclusive)
Body Mass Index (BMI) ranging from 18.5Kg/㎡ to 23.9Kg/㎡
Experienced at least 2 abortions or had a missed abortion
Confirmed gestational age of no more than 10 weeks, and the ultrasonic examinationwithin three days prior to the surgery shows a gestational sac (average of threediameters) of at least 1.0cm, with an embryo length of no more than 3.0cm
Normal preoperative examination results as per the "Clinical Diagnosis and TreatmentGuidelines and Technical Operation Standards: Family Planning Volume (2017Revision)"
Capable of regular follow-ups and willing to sign the informed consent form.
Exclusion
Exclusion Criteria:
Individuals with contraindications to estrogen and progesterone therapy
History of uterine adhesions confirmed by hysteroscopy, or a history of uterinecavity surgery or uterine malformation correction
Subjects who require placement of an intrauterine device or administration of oralcontraceptives or subcutaneous implants after the procedure
Individuals with mental status or cognitive function abnormalities who are unable tocooperate with the treatment process
Subjects who, in the opinion of the investigator, have potential risks or any otherfactors that may interfere with the study.
Study Design
Study Description
Connect with a study center
Women's Hospital School Of Medicine Zhejiang University
Hangzhou, Zhejiang 310006
ChinaSite Not Available
Women's Hospital School Of Medicine Zhejiang University
Hangzhou 1808926, Zhejiang 1784764 310006
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.